|
LRRC8D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.023600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.761600E-02 |
| Normal-vs-Stage2 |
6.075200E-01 |
| Normal-vs-Stage3 |
6.314500E-02 |
| Normal-vs-Stage4 |
1.297420E-01 |
| Stage1-vs-Stage2 |
2.636800E-01 |
| Stage1-vs-Stage3 |
6.473800E-01 |
| Stage1-vs-Stage4 |
9.386600E-01 |
| Stage2-vs-Stage3 |
2.764000E-01 |
| Stage2-vs-Stage4 |
4.402400E-01 |
| Stage3-vs-Stage4 |
8.502800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.584200E-02 |
| Normal-vs-AfricanAmerican |
3.053600E-01 |
| Normal-vs-Asian |
5.257400E-01 |
| Caucasian-vs-AfricanAmerican |
1.926370E-01 |
| Caucasian-vs-Asian |
9.995600E-02 |
| AfricanAmerican-vs-Asian |
3.506200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.036500E-02 |
| Normal-vs-Female |
3.478000E-01 |
| Male-vs-Female |
1.447230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.503020E-01 |
| Normal-vs-Extreme_Weight |
2.279600E-03 |
| Normal-vs-Obese |
1.284390E-01 |
| Normal-vs-Extreme_Obese |
2.085200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.555200E-01 |
| Normal_Weight-vs-Obese |
9.323200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.870600E-01 |
| Extreme_Weight-vs-Obese |
1.068360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.457800E-01 |
| Obese-vs-Extreme_Obese |
8.211600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.744170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.578200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.346400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.473400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.308800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.534400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.866000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.964240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.361600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.880200E-02 |
| Normal-VS-Type2 PRCC |
7.334400E-02 |
| Normal-VS-KIRP CIMP |
2.698800E-03 |
| Normal-VS-Unclassified PRCC |
6.676000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.161000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.695500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.587600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.417190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.817400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.715600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.568770E-01 |
| Normal-vs-N1 |
1.705010E-01 |
| Normal-vs-N2 |
7.557800E-03 |
| N0-vs-N1 |
8.211400E-01 |
| N0-vs-N2 |
8.225900E-02 |
| N1-vs-N2 |
1.627600E-01 |
|
|
